# XELJANZ

NDC: 0069-1001
Generic name: tofacitinib
Labeler / Manufacturer: Pfizer Laboratories Div Pfizer Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20121109

FDA application: NDA203214

## Active ingredients

- TOFACITINIB CITRATE: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0069-1001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0069-1001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cf74ba2f-afc5-4baa-8594-979c889a5831